1. Home
  2. NSPR vs FTHM Comparison

NSPR vs FTHM Comparison

Compare NSPR & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$0.85

Market Cap

33.7M

Sector

Health Care

ML Signal

HOLD

Logo Fathom Holdings Inc.

FTHM

Fathom Holdings Inc.

HOLD

Current Price

$0.72

Market Cap

28.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSPR
FTHM
Founded
2005
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
33.7M
28.8M
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
NSPR
FTHM
Price
$0.85
$0.72
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$4.00
$2.50
AVG Volume (30 Days)
75.5K
130.9K
Earning Date
05-04-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.71
EPS
N/A
N/A
Revenue
$2,310,000.00
$420,477,000.00
Revenue This Year
$57.98
$11.67
Revenue Next Year
$95.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.45
52 Week Low
$0.63
$0.40
52 Week High
$2.57
$3.37

Technical Indicators

Market Signals
Indicator
NSPR
FTHM
Relative Strength Index (RSI) 58.52 41.95
Support Level $0.66 $0.70
Resistance Level $1.04 $0.92
Average True Range (ATR) 0.07 0.06
MACD 0.02 -0.01
Stochastic Oscillator 54.65 15.39

Price Performance

Historical Comparison
NSPR
FTHM

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, and Software as a Service (SaaS) offerings to brokerages and agents by leveraging intelliAgent , proprietary cloud-based software. The Company's three operating and reportable segments: Real Estate Brokerage, Mortgage, and Title. The majority of revenue is from Real Estate Brokerage, which provides real estate brokerage services.

Share on Social Networks: